MY196688A - Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
- Google Patents
Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies GmbhfiledCriticalImmatics Biotechnologies Gmbh
Priority to MYPI2019005926ApriorityCriticalpatent/MY196688A/en
Publication of MY196688ApublicationCriticalpatent/MY196688A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
MYPI2019005926A2017-10-312017-10-31Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
MY196688A
(en)